|Home | About | Journals | Submit | Contact Us | Français|
Epidemiologic data suggest an association between obesity and depression, but findings vary across studies and suggest a stronger relationship in women than men.
To evaluate the relationship between obesity and a range of mood, anxiety, and substance use disorders in the US general population.
Cross-sectional epidemiologic survey
Nationally representative sample of US adults
9125 respondents who provided complete data on psychiatric disorder, height and weight. Response rate was 71%.
Participants completed an in-person interview including assessment of a range of mental disorders (assessed using the WHO Composite International Diagnostic Interview) as well as height and weight (by self-report).
Obesity (defined as Body Mass Index of 30 or more) was associated with significant increases in lifetime diagnosis of major depression (Odds Ratio (OR)=1.21, 95% Confidence Interval (CI) 1.09 to 1.35), bipolar disorder (OR=1.47, 95% CI 1.12 to 1.93), and panic disorder or agoraphobia (OR=1.27, 95% CI 1.01 to 1.60). Obesity was associated with significantly lower lifetime risk of substance use disorder (OR=0.78, 95% CI 0.65 to 0.93). Subgroup analyses found no difference in these associations between men and women, but the association between obesity and mood disorder was strongest in non-Hispanic whites (OR=1.40, 95% CI 1.20 to 1.64) and college graduates (OR=1.52, 95% CI 1.17 to 1.98).
Obesity is associated with an approximately 25% increase in odds of mood and anxiety disorders and an approximately 25% decrease in odds of substance use disorders. Variation across demographic groups suggests that social or cultural factors may moderate or mediate the association between obesity and mood disorder.
The increasing prevalence of overweight and obesity is a major public health concern. Among US adults, prevalence of obesity (defined as a Body Mass Index or BMI of 30 or more) increased from approximately 23% in 1990 to 31% in 20001. Similar increases were seen for men and women, across all age groups, and across all racial/ethnic groups.1,2 More recent data indicate no decline in obesity rates between 2000 and 20022. Given the expected increases in diabetes, cardiovascular disease, and other adverse consequences of obesity, increasing obesity rates are expected to produce an unprecedented decline in life expectancy in the United States 3.
Regulation of weight is a complex phenomenon subject to a range of individual-level and community-level influences. In the US, obesity prevalence is higher among middle-aged and older than younger adults 1,2. Obesity is also more common among Hispanics and African Americans than other racial/ethnic groups 1,2, with racial/ethnic differences greater among women than men2. In developed economies, obesity is inversely associated with income and other indicators of socioeconomic status 4-6, but this relationship may be weakening over time5. At the community level, obesity is associated with greater access to inexpensive, calorie-dense foods 4,7,8 and with reduced opportunities for physical activity9.10
Previous research suggests that obesity may be significantly associated with mood disorders 11,12. Several community surveys in the US and Canada have found associations between obesity and depressive symptoms 13,14, history of depression 15, and measures of psychological distress 16. Several US surveys have observed sex differences in this relationship, with positive associations between obesity and depression among women and either negative or no associations among men 17-20. On US survey 14 suggests a stronger association between obesity and depression among those under age 65. Community survey data from the 1950s suggest a stronger association between obesity and depression among those with higher socioeconomic status 21. The associations between depression and obesity observed in largely Caucasian samples in the US and Canada, however, may not extend to other cultural or ethnic groups 22,23. Longitudinal studies have found that depression predicts the subsequent onset of obesity 24,25, that obesity predicts the subsequent onset of depression 26, that successful weight loss is associated with decreased depression 27, and that depression predicts poorer success in weight loss 28,29.
Limited epidemiologic data address the relationship between obesity and anxiety or substance use disorders. Anxiety symptoms have shown moderate positive associations with obesity in community 30 and clinic 31,32 samples. Alcohol abuse has been associated with lower risk of overweight and obesity 33.
Here we use data from the National Comorbidity Survey Replication to examine whether associations between depression and obesity continue to appear in the most recent survey of mental disorders in the US and whether those associations extend to other mental disorders. We focus on the following questions: What are the current associations between obesity and a range of common mental disorders (mood, anxiety, and substance use disorders) in the US population? Do these associations vary according to sociodemographic characteristics: sex, age, race/ethnicity, and educational attainment (demographic characteristics consistently associated with obesity in the US population)?
The National Comorbidity Survey Replication or NCS-R was an in-person survey of a nationally representative sample of US residents conducted between February of 2001 and December of 2002. Respondents were selected from a multistage area probability sample of the non-institutionalized civilian population in the 48 contiguous states. The response rate was 70.9%. More complete information on the methods of the NCS-R is presented elsewhere 34,35.
Potential participants were mailed a letter and study fact brochure followed by an in-person interviewer visit. Interviewers explained the study procedures and obtained verbal informed consent before beginning the interview. Participants received $50 as a gift to thank them for participating. Recruitment and consent procedures were approved by human subjects committees of Harvard Medical School and the University of Michigan.
Professional non-clinician interviewers from the Institute for Social Research at the University of Michigan conducted all assessments. More than 300 interviewers participated in the study, each receiving 7 days of study-specific training and successfully completing 2 practice interviews before beginning field work. Interviews were administered using laptop computer-assisted software that included built-in skip logic, timing flags, and consistency checks. Regional supervisors re-contacted a random 10% of respondents for quality control.
Mental disorders were assessed using the World Mental Health version of the WHO Composite International Diagnostic Interview (CIDI). This fully structured diagnostic assessment was developed for use by trained non-clinician interviewers in diverse community populations. Mental disorder diagnoses are based on criteria of the American Psychiatric Association’s Diagnostic and Statistical Manual, 4th Edition or DSM-IV. Diagnoses considered in this report include mood disorders (major depression, dysthymia, bipolar disorder I or II), anxiety disorders (panic disorder, agoraphobia without panic, generalized anxiety disorder), and substance use disorders (alcohol abuse and dependence, drug abuse and dependence). Previous research has documented good concordance between the NCS-R CIDI diagnoses and blind clinical diagnoses, with the CIDI generally having a higher diagnostic threshold in comparison to blind clinical diagnoses 36.
Demographic characteristics (age, sex, race/ethnicity), height, and weight were assessed by participants’ self reports. Previous methodologic research suggests that self-reported height and weight are highly correlated with direct physical measurements 37-39, but self-report tends to consistently under-estimate weight and over-estimate height 38-41, leading to low estimates of overweight and obesity.
All analyses were based on weighted data and implemented using SUDAAN statistical software (Research Triangle Institute, 2002). The clustered sampling design of the NCS-R study could lead to over-estimation of statistical significance (i.e. design effect). Consequently, significance tests, standard errors and 95% confidence intervals were estimated using the Taylor Series method (delta method). All significance tests were made using two-sided tests evaluated at the 0.05 level of significance.
This report includes 9125 NCS-R respondents (of 9282 possible) who provided data on height and weight. Table 1 compares respondents with BMI less than 30 to those with BMI of 30 or more. As expected, those higher BMI were more often African American or Hispanic and were less likely to have completed more than 12 years of education.
As shown in Table 2, lifetime prevalence estimates for mood and anxiety disorders are all higher among those with BMI of 30 or more than among those with BMI less than 30. Odds ratios comparing rates of specific mood and anxiety disorders in the obese and non-obese groups range from approximately 1.2 to 1.5. A similar pattern was seen for prevalence of mood or anxiety disorders in the last 12 months with odds ratios in the range 1.1 to 1.6. In contrast, lifetime and past-year prevalence estimates for substance use disorders are significantly lower in those with BMI of 30 or more. Some relationships (e.g. major depression, any mood disorder) are statistically significant for lifetime diagnosis and not so for past-year diagnosis. This discrepancy, however, reflects wider confidence intervals (due to lower prevalence rate and smaller number of cases) rather than clinically or statistically significant differences in odds ratios.
Subgroup analyses examined the relationship between obesity and mood disorders across different sociodemographic groups (Table 3). This association did not vary significantly between men and women (p=.65 for interaction). While the association between obesity and mood disorder appears stronger among younger respondents, a formal test for interaction finds no significant variation with age (p=.40 for interaction with years of age as continuous measure). The association between obesity and mood disorder is only statistically significant among respondents with more than 12 years of education, and a formal test for interaction finds significant variation by years of educational attainment (p=.007 for interaction with years of education as continuous measure). The association between obesity and mood disorder is statistically significant only among non-Hispanic Whites. A formal test for interaction finds a borderline significant difference in odds ratios between non-Hispanic Whites and other racial/ethnic groups (p=.058 for interaction with non-Hispanic Whites vs. other racial/ethnic groups). The two left columns of Table 3 display the variation in mood disorder prevalence and obesity prevalence by age, educational attainment, and race/ethnicity. The sociodemographic groups showing the strongest association between obesity and depression (age 29 or younger, college education or greater, Non-Hispanic Whites) are also among the groups with the lowest prevalence of obesity.
Parallel subgroup analyses examined the association between obesity and anxiety disorders across demographic groups (Table 4). This association does not vary significantly according to sex (p=.52), age (p=.13), or race/ethnicity (p=.21). The association is strongest in those with the highest educational attainment, and a formal test for interaction is marginally significant (p=.059 for interaction with years of education as a continuous measure).
A third set of subgroup analyses examined variation in the association between obesity and substance use disorders (Table 5). This negative association does not vary significantly by sex (p=.46), age (p=.22), race/ethnicity (p=.43), or educational attainment (p=.36).
The final set of analyses considered potential confounders that might magnify or obscure associations between obesity and psychiatric disorders. Adjustment for age and sex has no effect on the observed associations (second column of Table 6). While smoking is positively associated with psychiatric disorder and negatively associated with obesity, adjustment for smoking status has no meaningful effect on associations between obesity and mood disorder, anxiety disorder, or substance use disorder (third column of Table 6). Finally, adjustment for comorbid psychiatric disorder (e.g. effect of substance use disorder adjusted for mood and anxiety disorders) also had no meaningful effect on observed associations (fourth column of Table 6).
We observed significant positive associations between obesity and a range of mood and anxiety disorders in a nationally representative sample of the US household population. In contrast, substance use disorders were associated with significantly lower risk of obesity. These associations were not explained by confounding due to age, sex, smoking, or comorbid psychiatric disorders. Mood and anxiety disorders each made independent contributions to obesity risk.
The positive associations between obesity and mood or anxiety disorders were generally modest, with odds ratios in the range 1.2 to 1.5. Even these modest associations carry public health significance, though, given the high overall prevalence of obesity (approximately 25%) and mood or anxiety disorders (approximately 25%). The estimated prevalence of lifetime mood disorder in those with BMI below and above 30 translate to a population attributable risk of 24%, that is nearly one quarter of cases of obesity in the general population are attributable to the association with mood disorder. This calculation illustrates the public health importance of the association, but does not indicate a direction for the causal relationship. It is equally correct to state that over one fifth of cases of mood disorder in the general population are attributable to the association with obesity (population attributable risk of 21%). We have no way of distinguishing the direction of the causal relationship between obesity and psychiatric disorders nor the possibility that unmeasured common causes induce an association between them.
The National Comorbidity Survey Replication offers several advantages over previous community surveys used to examine associations between psychiatric disorder and obesity. First, the sample was designed to be an accurate representation of the non-institutionalized population of the 48 contiguous United States. Results can therefore be generalized to this population. Second, the survey assessed a full range of psychiatric and substance use disorders, allowing us to examine associations with anxiety disorders, bipolar disorder, and substance use disorders. Third, mental disorders were assessed using a well-validated structured diagnostic interview, which allowed the association of obesity with these disorders to be assessed with accuracy. Fourth, the assessment considered lifetime diagnoses as well as current state. Assessment of lifetime diagnosis is preferable because an association between weight and psychiatric disorder would be expected to reflect long-term behavioral and/or biological mechanisms.
The associations between obesity and psychiatric disorders in this sample did not vary between men and women. This contrasts with findings in other US national surveys 17-20 that positive associations between obesity and depression exist among women while negative or absent associations exist among men. We are unable to identify any consistent differences in methods between our study and previous studies that would explain why earlier studies found no association between obesity and depression in men while such an association was observed in the NCS-R sample. In one earlier study the magnitude of the odds ratio between obesity and depression in men was similar to that in women, but the lower prevalence of depression in men led to a wider confidence interval and a statistically insignificant result 20. A similar phenomenon is seen in this sample for both mood and anxiety disorders. Because we observe no statistically significant interaction with sex, we conclude that this discrepancy (significant association in women but not in men) probably reflects differences in statistical power rather than differences in magnitude of the association.
Most previous research has focused on the association between obesity and depression, and various mechanisms have been proposed to explain this relationship 11,12,42. Some of those mechanisms propose a causal pathway leading from depression to obesity. Increased appetite and weight gain are common symptoms of depression 43,44, and tendency to gain weight remains stable across depressive episodes 43. Depression may lead to reduced physical activity 45, increasing risk for obesity. Depression may increase risk of weight gain through its effect on binge eating 46,47, especially among women 28,48. Medications used to manage mood or anxiety disorders may also lead to weight gain 49. Alternatively, some proposed mechanisms suggest a causal relationship leading from obesity to depression. The stigma attached to obesity (especially for women) may contribute to depression 50,51. Activity limitations due to obesity or obesity-related chronic illnesses may increase risk of depression by reducing involvement in rewarding or pleasurable activities 30. Finally, depression and obesity may be linked through some common cause or third factor, either environmental (e.g. childhood abuse 52) or biological.
We observe interesting variation in the relationship between obesity and mood disorder across sociodemographic groups. The association appeared stronger in younger than older respondents, in non-Hispanic Whites than other racial/ethnic groups, and in respondents with higher educational attainment. Only the interaction with educational attainment, however, was significant at the 5% level. Approximately 40 years ago, The Midtown Manhattan Study in the 1950s 21 also observed that, among women, the association between obesity and depression was confined to those with higher socioeconomic status. In the NCS-R sample, the groups showing the strongest association between obesity and mood disorder were also the groups with the lowest overall rates of obesity. A similar phenomenon has been observed regarding the association between depression and tobacco use; as rates of tobacco use decline, the association between tobacco use and depression grows stronger 53.
Our findings are consistent with either direction of causal relationship between obesity and mood or anxiety disorders. If stigmatization of overweight and obesity causes or contributes to mood and anxiety disorders, the effects of stigma might be more powerful in sociodemographic groups with lower obesity rates. Some previous research suggests that self-perception of overweight 54,55 and the perceived stigma associated with obesity 56-59 may both be greater in Caucasians and those with higher income or educational attainment. Alternatively, if mood or anxiety disorders contribute to obesity through an effect on health behaviors (reduced physical activity, increased caloric intake), then this effect could be more easily expressed in sociodemographic groups with lower obesity rates. This cross sectional study does not allow us to distinguish between causal mechanisms or examine how they might differ across sociodemographic groups.
Our findings also do not indicate a specific mechanism or causal direction for the observed negative association between obesity and substance use disorders. While alcohol or other substances may have a direct effect on appetite or caloric intake, a negative association was also observed in those with histories of substance abuse (i.e. lifetime substance use disorder not active in the last 12 months).
We conclude that obesity is meaningfully associated with a range of common mood and anxiety disorders in the general US population. Obesity is associated with a moderately lower risk of substance use disorder. Variation in the obesity-depression relationship by educational level and race/ethnicity suggests an important role for social or cultural factors in mediating or moderating the relationship between obesity and mood disorders. Clarifying the social and cultural influences on the relationship between obesity and mood or anxiety disorders will require additional research in populations with a broader range of race/ethnicity, educational attainment, and income. Clarifying the direction of causal relationships will require alternative research designs, including longitudinal and experimental studies.
Preparation of this report was supported by NIMH grants R01MH069864 and R01MH68127. The National Comorbidity Survey Replication (NCS-R) is supported by NIMH (U01-MH60220) with supplemental support from NIDA, the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. Preparation of the current report was additionally supported by NIMH Grant R01-MH069864. Collaborating NCS-R investigators include Ronald C. Kessler (Principal Investigator, Harvard Medical School), Kathleen Merikangas (Co-Principal Investigator, NIMH), James Anthony (Michigan State University), William Eaton (The Johns Hopkins University), Meyer Glantz (NIDA), Doreen Koretz (Harvard University), Jane McLeod (Indiana University), Mark Olfson (Columbia University College of Physicians and Surgeons), Harold Pincus (University of Pittsburgh), Greg Simon (Group Health Cooperative), Michael Von Korff (Group Health Cooperative), Philip Wang (Harvard Medical School), Kenneth Wells (UCLA), Elaine Wethington (Cornell University), and Hans-Ulrich Wittchen (Max Planck Institute of Psychiatry). The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or U.S. Government. A complete list of NCS publications and the full text of all NCS-R instruments can be found at http://www.hcp.med.harvard.edu/ncs. The NCS-R is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. These activities were supported by the National Institute of Mental Health (R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Pan American Health Organization, Eli Lilly and Company, and GlaxoSmithKline. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmhcidi.